In addition, in terms of article types, we only included reviews and Articles for analysis, which might also lead to data omissions
Exenatide: Another GLP-1 receptor agonist used to manage type 2 diabetes, similar in function to semaglutide
Pieber TR, Bode B, Mertens A, Cho YM, Christiansen E, Hertz CL, et al
As more pharmaceutical companies develop similar medications, competition may eventually influence pricing and expand treatment access
NICE guidance recommends GLP-1 receptor agonists as treatment options for type 2 diabetes in specific circumstances, typically when other medications have not achieved adequate glycaemic control or when weight loss would provide additional benefit